Company: ASB
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0000007789-25-000179
Chunk: 307

Company: ASSOCIATED BANC-CORP
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 8
Chunk 307
---
 foregoing, its Chief Executive Officer and Chief Financial Officer concluded that the Corporation’s disclosure controls and procedures were effective as of September 30, 2025. 

No changes were made to the Corporation’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Corporation’s internal control over financial reporting.

78

PART II - OTHER INFORMATION

ITEM 1.Legal Proceedings

The information required by this item is set forth in Part I, Item 1 under Note 11 Commitments, Off-Balance Sheet Arrangements, Legal Proceedings, and Regulatory Matters of the notes to consolidated financial statements. 

ITEM 1A.Risk Factors 

There have been no material changes in the Risk Factors described in the Corporation’s 2024 Annual Report on Form 10-K.

ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds

During the third quarter of 2025, the Corporation repurchased common stock, of which all were related to tax withholding on equity compensation. The repurchase details are presented in the table below:

Common Stock PurchasesTotal Number  ofShares Purchased(a)Average PricePaid per ShareTotal Number ofShares Purchased asPart of PubliclyAnnounced Plansor ProgramsMaximum Number ofShares that May YetBe Purchased Underthe Plansor Programs(b)PeriodJuly 1, 2025 - July 31, 20254,605 $25.82 — August 1, 2025 - August 31, 20253,352 24.74 — September 1, 2025 - September 30, 20255,979 24.13 — Total13,936 $24.83 — 1,519,429 

(a) As all of the repurchased shares were for minimum tax withholding settlements on equity compensation, these purchases do not count against the maximum value of shares remaining available for purchase under the Board of Directors' 2021 authorization.

(b) At September 30, 2025, there remained $39.1 million authorized to be repurchased under the Board of Directors' 2021 $100.0 million authorization. The maximum number of shares that may yet be purchased under this authorization is based on the closing share price on September 30, 2025